Alchelyst and Lyra Client Solutions Complete Combination, Creating a Purpose-Built Platform to Support the Evolving Needs of Private Markets March 12, 2026 Newly combined company will focus on delivering technology-enabled client service and next-generation infrastructure to support the growth of private markets firms
NAFFCO Group and Verona Shelters Launch Strategic Joint Venture to Scale Civil and Military Shelter Production Globally March 12, 2026 NAFFCO Group has entered into a Joint Venture Agreement with Verona Shelters to form a strategic partnership dedicated to developing and manufacturing advanced civil defense and military shelter solutions in the United Arab Emirates. The partnership significantly expands global production capacity for protective shelter infrastructure at a time when governments and critical industries are strengthening [...]
Level Access Supercharges Partner Program to Accelerate Digital Accessibility March 12, 2026 IBM, Slalom, Merkle, and more will harness the power of Level Access’s platform to deliver inclusive customer experiences
Texas Stock Exchange (TXSE) Selects Options’ AtlasInsight for Next Generation Packet Capture and Real Time Analytics March 11, 2026 Options Technology (Options), the leading provider of financial services infrastructure, today announced that its AtlasInsight platform has been selected by the Texas Stock Exchange (TXSE) to deliver high-fidelity packet capture and real-time analytics across TXSE’s proprietary, world-class trading infrastructure. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260311267175/en/ As TXSE prepares to launch [...]
Curatis and Neupharma Announce Exclusive Licensing Agreement to Develop and Market Corticorelin (C-PTBE-01) for the Treatment of Peritumoral Brain Edema in Japan March 11, 2026 Japan is one of the world's most important pharmaceutical markets after the US and Europe. Neupharma’s team has extensive experience in developing and successfully commercialising orphan drugs as well as speciality care medicines in Japan, including a blockbuster drug. The agreement with Neupharma includes upfront and milestone payments of up to CHF 83.5 million as well as royalties of up to 20% on sales. The population of available patients eligible for corticorelin treatment associated with peritumoral brain edema is estimated at 60,000 in Japan and 500,000 worldwide. Global market potential is forecasted to exceed USD 1 billion annually.
Wilson James Selects Legion’s AI-Powered Workforce Management Platform to Transform Workforce Operations March 10, 2026 Wilson James, a leading integrated solutions provider operating across aviation, security, infrastructure, and logistics, has selected Legion’s AI-powered Workforce Management (WFM) platform as part of a strategic transformation to redefine how complex, people-led operations are planned, managed, and optimised across its UK and international divisions. Operating in some of the most demanding and highly regulated [...]
Bregal Sphere and Imperative Partner With Ambition to Deploy up to $500 Million Into Global Nature Restoration Projects March 10, 2026 Bregal Sphere, part of Bregal Investments, today announced a strategic partnership with Imperative, providing financing to accelerate the development of its global pipeline of high-quality ecosystem restoration projects. As a leading institutional natural capital investor, Bregal Sphere partners with best-in-class developers to deliver large-scale carbon removal projects that generate meaningful impacts for nature, climate, and [...]
C-Further Unveils First Therapeutic Programmes Dedicated to Paediatric Oncology March 10, 2026 C-Further to advance its first two bespoke paediatric cancer therapeutics in collaboration with leading global academic and industry investigators Selected programmes to potentially address multiple children’s cancers including Ewing sarcoma, bone sarcoma, medulloblastoma and acute myeloid leukaemia Additional C-Further programmes to be announced in 2026
Amentum-led Joint Venture selected for $112 Million Clean-up at Four European Nuclear Research Sites March 10, 2026 A joint venture led by Amentum (NYSE: AMTM) has won a new framework contract as the lead decommissioning and waste management contractor for nuclear research sites in four European countries. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260310491705/en/ Under the $112 million (€95.7 million) contract, awarded by the European Commission Joint Research [...]
VIPR Announces Strategic Engagement with Aon to Transform Delegated Authority Operations March 10, 2026 Multi-year engagement to deliver intelligent automation and operational clarity across global reinsurance platform